9258 Wealth Management’s Novartis NVS Stock Holding History

9258 Wealth Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$257K	Sell	2,239 -85	-4%	-$9.64K	0.04%	293
2024 Q2	$247K	Buy	2,324 +20	+0.9%	+$2.01K	0.04%	291
2024 Q1	$223K	Sell	2,304 -10	-0.4%	-$1.02K	0.03%	312
2023 Q4	$234K	Sell	2,314 -7	-0.3%	-$676	0.04%	285
2023 Q3	$236K	Hold	2,321	–	–	0.05%	280
2023 Q2	$234K	Sell	2,321 -16	-0.7%	-$1.6K	0.04%	286
2023 Q1	$215K	Buy	2,337 +39	+2%	+$3.41K	0.04%	298
2022 Q4	$208K	Buy	+2,298	New	+$194K	0.05%	305
2022 Q3	–	Sell	-2,373	Closed	-$201K	–	338
2022 Q2	$201K	Sell	2,373 -382	-14%	-$33.5K	0.05%	317
2022 Q1	$242K	Sell	2,755 -138	-5%	-$11.9K	0.06%	317
2021 Q4	$253K	Buy	+2,893	New	+$240K	0.06%	320
2021 Q3	–	Sell	-2,224	Closed	-$203K	–	352
2021 Q2	$203K	Sell	2,224 -552	-20%	-$49.2K	0.05%	330
2021 Q1	$237K	Sell	2,776 -817	-23%	-$73.3K	0.07%	279
2020 Q4	$339K	Buy	3,593 +120	+3%	+$10.5K	0.11%	205
2020 Q3	$271K	Sell	3,473 -80	-2%	-$6.93K	0.1%	220
2020 Q2	$310K	Buy	3,553 +230	+7%	+$19.9K	0.13%	196
2020 Q1	$298K	Buy	3,323 +74	+2%	+$6.6K	0.13%	189
2019 Q4	$308K	Buy	+3,249	New	+$292K	0.11%	208

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

9258 Wealth Management's NVS Position: Q3 2024 in Review

9258 Wealth Management reduced its Novartis (NVS) stake by 3.7% in Q3 2024, selling an estimated $9.64K and leaving 2,239 shares worth $257K. The position accounts for 0.04% of the portfolio, ranked #293.

9258 Wealth Management first reported a position in NVS in Q4 2019 and has held it in 18 quarters since. The position peaked at $339K in Q4 2020. 1,311 funds tracked by Wall St. Rank hold NVS as of Q3 2024.

9258 Wealth Management held 2,239 shares of Novartis worth $257K as of Q3 2024.
9258 Wealth Management sold 85 Novartis shares in Q3 2024, an estimated $9.64K.
Novartis made up 0.04% of 9258 Wealth Management's portfolio in Q3 2024, its #293 holding.
9258 Wealth Management first reported a position in Novartis in Q4 2019 and has held it in 18 quarters since.
9258 Wealth Management's Novartis position peaked at $339K in Q4 2020.
1,311 funds tracked by Wall St. Rank held Novartis as of Q3 2024.

Based on 9258 Wealth Management's 13F filing for Q3 2024, filed 12 Nov 2024.